NeuroOne outlines ISO 13485 certification in latter part of 2026 while targeting drug delivery availability in second half of fiscal 2026
Source: SeekingAlpha
2026-05-12 11:11:55 ET
More on NeuroOne Medical Technologies
- NeuroOne Medical Technologies Corporation (NMTC) Q2 2026 Earnings Call Transcript
- NeuroOne Medical Technologies Corporation (NMTC) Discusses Platform Technology Advancements and Growth Plans for Neurological Device Applications Transcript
- NeuroOne Medical Technologies Corporation (NMTC) Q1 2026 Earnings Call Transcript
- NeuroOne targets at least $10.5M revenue in 2026 while advancing brain and pain therapy platforms
- Seeking Alpha’s Quant Rating on NeuroOne Medical Technologies
Read the full article on Seeking Alpha
For further details see:
NeuroOne outlines ISO 13485 certification in latter part of 2026 while targeting drug delivery availability in second half of fiscal 2026
NeuroOne Medical Technologies Corporation
NASDAQ: NMTC
NMTC Trading
-3.92% G/L:
$3.3915 Last:
9,999 Volume:
$3.54 Open:
NMTC Latest News
May 28, 2026 08:35:41 am
NeuroOne(R) to Present at the 2026 American Society for Stereotactic and Functional Neurosurgery Biennial Meeting on May 31, 2026
May 22, 2026 04:35:54 pm
NeuroOne(R) Medical Technologies Announces Restatement of Financial Results for Quarter Ending March 31, 2026
May 12, 2026 08:02:48 am
NeuroOne Reports Fiscal Q2 2026 Financial Results and Provides Corporate Business Update
NMTC Stock Data
$42,347,044
45,926,378
0.01%
16
N/A
Medical Equipment & Supplies
Healthcare
US
Eden Prairie
